Salute e Benessere
ESMO releases first-ever guidance for safe use of AI Language Models in cancer care
"Innovation must serve oncologists and, ultimately, patients, not confuse or mislead them," said Fabrice André, ESMO President. "With ELCAP, we offer a practical guide for using AI responsibly in oncology, one that protects data, ensures clinical oversight, and supports informed decision-making."
ELCAP divides AI applications into three categories, with specific safety and governance recommendations:
"The value of AI depends on who is using it," said Miriam Koopman , ESMO Real World Data and Digital Health Task Force Chair. "ELCAP sets expectations for each context, ensuring patients are protected, clinicians are supported, and institutions are accountable."
"Trust in AI doesn't come from technology alone, it comes from shared standards," concluded Andrè. "ELCAP is our contribution to making AI a safe and effective ally in oncology."
With 45,000 oncology professionals in its global network, ESMO can be looked up as the global reference for responsible AI adoption in cancer care.
Article here: https://www.annalsofoncology.org/article/%20S0923-7534(25)04698-8/fulltext
- Picture is available at AP -
Contact:
ESMO Press Office
press@esmo.org
+41 91 9731907
View original content:https://www.prnewswire.co.uk/news-releases/esmo-releases-first-ever-guidance-for-safe-use-of-ai-language-models-in-cancer-care-302588800.html